Clinical Trials on Portion Size in Switzerland

Total 1082 results

Swiss Group for Clinical Cancer Research

Completed

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer

Switzerland
European Organisation for Research and Treatment...

Completed

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

Brain and Central Nervous System Tumors

France, Australia, United Kingdom, Germany, Switzerland, Netherlands, Spain
CureVac

Completed

Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Switzerland, Germany
UroGen Pharma Ltd.

Completed

Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC (OPTIMA)

Carcinoma of Urinary Bladder, Superficial

Israel, Spain, Italy, Switzerland
University of Basel

Recruiting

Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland (CASCADE)

Lynch Syndrome | Hereditary Breast and Ovarian Cancer

Switzerland
European Organisation for Research and Treatment...
GlaxoSmithKline

Completed

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

Breast Cancer

France, United Kingdom, Belgium, Switzerland, Slovenia
European Institute of Oncology

Active, not recruiting

Sentinel Node Vs Observation After Axillary Ultra-souND (SOUND)

Early Stage Breast Carcinoma

Italy, Chile, Spain, Switzerland
Swiss Group for Clinical Cancer Research

Completed

Metronomic Therapy in Metastatic Breast Cancer.

Breast Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Small Cell Lung Cancer | Lung Cancer

Switzerland
Thomas Zilli

Active, not recruiting

Hypofractionated Radiation Therapy in Prostate Cancer

Malignant Neoplasm of Prostate | Local Disease

Netherlands, Israel, Switzerland, Spain, Belgium, Finland, Portugal, Turkey
Quantgene Inc.

Unknown

Circulating Tumor DNA Exposure in Peripheral Blood

Melanoma | Breast Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Other Cancer | Adrenocortical Cancer

Switzerland, United States
Swiss Group for Clinical Cancer Research

Completed

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer

Switzerland
European Organisation for Research and Treatment...

Completed

Synergism of Immunomodulation and Tumor Ablation (ILOC)

Colorectal Cancer | Liver Metastases

France, Netherlands, Switzerland, Germany, Austria, Sweden
CureVac

Terminated

Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Carcinoma

Germany, Switzerland, Austria
Saving Patients' Lives Medical B.V.
Radboud University Medical Center; ABX-CRO advanced pharmaceutical services... and other collaborators

Recruiting

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Prostate Cancer | Metastasis | Prostatectomy

Germany, Belgium, Netherlands, Switzerland
Swiss Group for Clinical Cancer Research

Completed

Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Malignant Mesothelioma

Switzerland, Germany
Novian Health Inc.

Recruiting

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Malignant Neoplasm of Breast

Switzerland, United States, Germany
European Organisation for Research and Treatment...

Completed

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

Ovarian Neoplasms

Spain, Switzerland, Netherlands, United Kingdom, France
UNICANCER

Completed

Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Lung Cancer

France, Switzerland, United Kingdom
Prof. Valérie Mc Lin
European Society of Pediatric Gastroenterology, Hepatology and Nutrition; European... and other collaborators

Enrolling by invitation

International Registry of Congenital Portosystemic Shunt (IRCPSS) (IRCPSS)

Congenital Porto-Systemic Shunt (CPSS)

Spain, United Kingdom, Canada, United States, Netherlands, France, Israel, Germany, Australia, Turkey, Switzerland, Japan, Belgium, Greece, Hungary, India, Italy
Swiss Group for Clinical Cancer Research

Terminated

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

Prostate Cancer | Cancer of the Prostate

Switzerland
Swiss Group for Clinical Cancer Research

Completed

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

Bladder Cancer

Switzerland, Germany
Swiss Group for Clinical Cancer Research

Active, not recruiting

Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

Switzerland
Ipsen

Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Gastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic Tumours

United States, France, Belgium, Switzerland, Netherlands
Swiss Group for Clinical Cancer Research

Completed

Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

NSCLC Non-small Cell Lung Cancer

Switzerland
ETOP IBCSG Partners Foundation
AstraZeneca

Recruiting

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)

Non-small Cell Lung Cancer | Oligometastasis | Stage IV

Switzerland, Netherlands, Spain, Italy
Terumo Europe N.V.

Completed

Holmium-166 Retrospective Collection of Real-World Data (RECORD)

Hepatocellular Carcinoma | Metastatic Cancer

Netherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer

Colorectal Cancer

Switzerland, Hungary
Hoffmann-La Roche

Completed

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Carcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell

United Kingdom, Czechia, Germany, Poland, Spain, Switzerland
Puma Biotechnology, Inc.

Completed

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Advanced Breast Cancer

United States, Switzerland, China, France
Swiss Group for Clinical Cancer Research

Active, not recruiting

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

Non-small Cell Lung Cancer | Malignant Pleural Mesothelioma

Switzerland
EMD Serono

Completed

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Carcinoma, Non-small-cell Lung

United States, Switzerland
Swiss Group for Clinical Cancer Research
Central European Cooperative Oncology Group

Completed

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

Switzerland, Italy, Israel, Austria
Interdisziplinare Arbeitsgruppe Gastrointestinaler...

Completed

Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery

Pancreatic Cancer

Switzerland, Germany, Austria
Swiss Group for Clinical Cancer Research

Completed

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

Lung Cancer

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Colorectal Cancer

Switzerland, Germany
ETOP IBCSG Partners Foundation
Merck Sharp & Dohme LLC; Frontier Science Foundation, Hellas

Completed

PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma (PROMISE-meso)

Pleural Mesothelioma Malignant Advanced

United Kingdom, Switzerland, Spain
Ipsen

Terminated

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) (SSTR2+)

Small Cell Lung Cancer and Breast Cancer

United States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
Novartis Pharmaceuticals

Terminated

HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma

Renal Cell Carcinoma | Epithelial Ovarian Cancer

Japan, Australia, Belgium, Spain, United States, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer

Adenocarcinoma | Breast Cancer

Switzerland
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
University of Zurich

Completed

Multicentric Prospective Validation of the Zurich Pituitary Score

Pituitary Adenoma

Switzerland, United States, Austria, Canada, Czechia, Italy
Varian, a Siemens Healthineers Company

Completed

Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy

Lung Cancer

United States, Switzerland, Germany, South Africa
ETOP IBCSG Partners Foundation
USZ Foundation

Recruiting

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer (USZ-STRIKE)

Melanoma | Non-Small Cell Lung Cancer

Switzerland, Netherlands, Italy, United Kingdom
European Organisation for Research and Treatment...

Completed

Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

France, Switzerland, Israel, Germany, Netherlands, Denmark, Greece
Novartis Pharmaceuticals

Completed

Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients

Breast Cancer | Hematologic Neoplasms

Netherlands, Switzerland, United Kingdom, United States
European Organisation for Research and Treatment...

Completed

Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

Breast Cancer

France, Spain, Netherlands, United Kingdom, Italy, Israel, Switzerland, Greece, Austria
Swiss Group for Clinical Cancer Research

Completed

Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients

Lung Cancer

Germany, Serbia, Switzerland
Swiss Group for Clinical Cancer Research

Terminated

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Colorectal Cancer

Switzerland
Boston Scientific Corporation
Biocompatibles UK Ltd

Completed

Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation (PRECISIONV)

Primary Liver Cancer

Austria, Switzerland, France, Germany

Clinical Trials on Portion Size in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations